Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635c4 Acutus Medical NASDAQAFIB

CARLSBAD, Calif., April 03, 2023 (GLOBE NEWSWIRE) — Acutus Medical, Inc. (“Acutus” or the “Company”) AFIB, an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, granted equity awards on April 1, 2023 that were approved by the Compensation Committee of its Board of Directors under Company’s 2022 Inducement Equity Incentive Plan, as a material inducement to employment to 7 individuals hired by Acutus in March 2023. The equity awards were approved in accordance with Nasdaq Listing Rule 5635(c)(4). The employees received, in the aggregate, 54,700 restricted stock units (“RSUs”). One-fourth of the RSUs granted…